CVE-2021-23233 Fresenius Kabi Agilia Connect Infusion System

High 7.3 Published 21 Jan 2022 Updated 16 Apr 2025

Unauthenticated attackers can access sensitive endpoints to perform critical actions or modify configuration parameters in the Agilia Link+ infusion system.

Exploited in the wild: Not known
Login needed: Not needed
Attackable: Over the internet
Victim action needed: Not needed
Fix: None listed

What is CVE-2021-23233?

CVE-2021-23233 is a high-severity missing authorization vulnerability in Fresenius Kabi Agilia Link+, published on 21 Jan 2022. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

Sensitive endpoints in Fresenius Kabi Agilia Link+ v3.0 and prior can be accessed without any authentication information such as the session cookie. An attacker can send requests to sensitive endpoints as an unauthenticated user to perform critical actions or modify critical configuration parameters.

Weakness: CWE-798, CWE-284

Which versions are affected by CVE-2021-23233?

It affects 6 products.

Products include Fresenius-Kabi Agilia Connect Firmware, Fresenius-Kabi Agilia Partner Maintenance Software, Fresenius-Kabi Link\+ Agilia Firmware, Fresenius-Kabi Vigilant Centerium, Fresenius-Kabi Vigilant Insight, Fresenius-Kabi Vigilant Mastermed.

How do I fix CVE-2021-23233?

No fix has been published for CVE-2021-23233 yet. Limit exposure of the affected software until one is available.

Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.

Is CVE-2021-23233 being exploited?

There is no known exploitation of CVE-2021-23233 in the wild and no public exploit code.

Sources

Also known as GHSA-2vv3-q2gp-2rjv.